Company: INTS
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001628279-25-000170
Chunk: 68

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-28
Form: DRS
Chunk 68
---
 06/29/2023  |     | 333-260565  |
| 23.1*   |     | Consent of EisnerAmper LLP, independent registered public accounting firm                                                                                                                                             |     |          |     |                  |     |             |     |             |
| 23.2*   |     | Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in Exhibit 5.1)                                                                                                                              |     |          |     |                  |     |             |     |             |
| 24.1*   |     | Power of attorney (included on the signature page)                                                                                                                                                                    |     |          |     |                  |     |             |     |             |
| 107*    |     | Filing Fee Table                                                                                                                                                                                                      |     |          |     |                  |     |             |     |             |

__________________

# Certain information has been excluded from the exhibit because it both (i) is not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed.
+ Denotes management compensation plan or contract.

* To be filed by amendment.

## Item 17. Undertakings
We hereby undertake:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933 (the “Securities Act”);

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

<div align='center'>II-5

Confidential Treatment Requested by Intensity Therapeutics, Inc.</div>

#### Pursuant to 17 C